"While I offer no opinion as to whether Judge Roberts harbors any actual bias in favor of pharmaceutical companies, specifically including GSK, there are many reasons why Judge Roberts’ ability to rule impartially in this case may reasonably be questioned,” Stengel wrote.
July 05, 2024 at 02:36 PM
3 minute read
Litigation Reporter
The original version of this story was published on The Legal Intelligencer
The plaintiffs in Philadelphia’s mass tort over the antacid Zantac are asking the supervising coordinating judge to recuse himself from the case.
The plaintiffs contend that Judge Joshua Roberts of the Philadelphia Court of Common Pleas has ties to a key drugmaker defendant through his wife’s position at an Am Law 200 law firm representing the company in the national litigation.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Skolnick Legal Group, P.C., a construction and commercial litigation firm with offices in New Jersey and New York is seeking a Litigation As...
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
Credit: Amy Lutz/Shutterstock.com
